219 related articles for article (PubMed ID: 4116558)
21. Cytological and functional criteria for the classification of malignant lymphomata.
Lennert K; Stein H; Kaiserling E
Br J Cancer Suppl; 1975 Mar; 2():29-43. PubMed ID: 52366
[TBL] [Abstract][Full Text] [Related]
22. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.
Stein H; Lennert K; Feller AC; Mason DY
Adv Cancer Res; 1984; 42():67-147. PubMed ID: 6395656
[No Abstract] [Full Text] [Related]
23. Examinations of the bactericidal properties of the serum against gram-positive microbes in patients suffering from leukaemia, malignant lymphoma, myeloma and myelofibrosis.
Libánský J; Jezková Z
Experientia; 1964 Mar; 20(3):124-7. PubMed ID: 5322537
[No Abstract] [Full Text] [Related]
24. [Quantitative immunoglobulin determination in paraproteinemias, lymphogranulomatosis and lympho-reticulosarcomatosis].
Patakfalvi A; Simon K; Horváth T; Böhm G
Orv Hetil; 1971 Jan; 112(2):75-8. PubMed ID: 4924220
[No Abstract] [Full Text] [Related]
25. [Immunologic deficiencies in malignant diseases of the lymphoma group and in multiple myeloma].
Hartl W; Hayduk K
Arch Klin Med; 1967 Nov; 214(1):54-69. PubMed ID: 4872039
[No Abstract] [Full Text] [Related]
26. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
Cohnen G; Augener W; Douglas SD; König E; Brittinger G
Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
[No Abstract] [Full Text] [Related]
27. Surface IgD in immunoproliferative disorders.
Preud'homme JL; Brouet JC; Clauvel JP; Seligmann M
Scand J Immunol; 1974; 3(6):853-8. PubMed ID: 4218365
[No Abstract] [Full Text] [Related]
28. [Immunopathology in lymphatic systemic diseases].
Huber H; Huber C; Michlmayr G
Verh Dtsch Ges Inn Med; 1973; 79():159-67. PubMed ID: 4133402
[No Abstract] [Full Text] [Related]
29. [Studies of cell content and surface and secretory immunoglobulins in myeloma, macroglobulinemia, malignant lymphoma and related leukemic diseases].
Miyoshi K; Kosaka M; Tamora R; Numata Y; Takamato M
Nihon Rinsho; 1976 May; 34(5):945-53. PubMed ID: 824476
[No Abstract] [Full Text] [Related]
30. Lymphocyte transformation in diseases of lymphoid tissue.
Pentycross CR
Proc R Soc Med; 1970 Apr; 63(4):355-7. PubMed ID: 4909839
[No Abstract] [Full Text] [Related]
31. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
[No Abstract] [Full Text] [Related]
32. [Significance of the HL-A-antigensystem in tumor research].
Kuwert E; Bertrams J
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):204-18. PubMed ID: 4264844
[No Abstract] [Full Text] [Related]
33. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
Ponzone A; Tarocco RP; Nicola P
Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
[No Abstract] [Full Text] [Related]
34. [Culture of peripheral lymphocytes in chronic malignant lymphoadenopathies].
Giraudo Conesa LC; Braun M; Bachmann AE; Pavlovsky A
Prensa Med Argent; 1971 Aug; 58(23):1160-2. PubMed ID: 4940640
[No Abstract] [Full Text] [Related]
35. B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.
Seligmann M; Preud'Homme JL; Brouet JC
Transplant Rev; 1973; 16():85-113. PubMed ID: 4204588
[No Abstract] [Full Text] [Related]
36. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical demonstration of cell surface antigens on tissue sections of lymphomas.
Hoffmann-Fezer G; Thierfelder S; Pielsticker K; Rodt H
Leuk Res; 1979; 3(5):297-304. PubMed ID: 392200
[No Abstract] [Full Text] [Related]
38. Immunologic markers of non-Hodgkin's lymphomas.
Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
Recent Results Cancer Res; 1978; 64():138-45. PubMed ID: 366692
[No Abstract] [Full Text] [Related]
39. [Immunological behavior of patients with malignant blood diseases].
Luca N
Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
[No Abstract] [Full Text] [Related]
40. Familiar B-cell neoplasms and HLA antigens.
Nigro M; De Rosa G; Camera A; Minerva A; Venuta S; Rotoli B
Haematologica; 1985; 70(5):465. PubMed ID: 3937792
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
